IN-SILICO DESIGN, SYNTHESIS AND IN VITRO ANTICANCER AND ANTITUBERCULAR ACTIVITY OF NOVEL AZETIDINONE CONTAINING ISATIN DERIVATIVES

Abstract

Objective: To design, synthesize and in vitro anticancer and antitubercular evaluation of some new isatin derivatives containing azetidinone.Methods: Novel azetidinone containing isatin derivatives were designed by using various softwares such as ACD Lab ChemSketch 12.0, Marvin Sketch, Molinspiration, PASS and Schrodinger. The designed molecules having required physico-chemical properties, drug likeness and obeying Lipinski’s rule of five were selected for the synthesis. These compounds were synthesized by conventional and microwave assisted synthetic methods through a series of three steps. The synthesized compounds were subjected to TLC, melting point determination, IR, 1HNMR and Mass spectroscopic studies. The in vitro anticancer activity of selected compounds was evaluated against MCF7 and L929 by MTT assay method. The antitubercular activity of selected compounds was evaluated by REMA method. Results: Ten derivatives (AZ-2, AZ-3, AZ-5, AZ-8, AZ-9, AZ-10, AZ-12, AZ-13, AZ-14 and AZ-15) were selected for synthesis with the help of in-silico modeling. In the synthesis, the microwave method took minimum reaction time and gave maximum yield comparing with conventional method. All the synthesized compounds showed characteristic peak in IR, 1HNMR and Mass spectroscopic studies. Based on the Schrodinger Glide XP score, the compounds AZ-13, AZ-5 and AZ-3 were selected for in vitro anticancer and AZ-9, AZ-14 and AZ-3 were selected for antitubercular evaluation. The compound AZ-13 showed significant anticancer activity particularly against L929 cell line and the compound AZ-9 showed significant antitubercular activity comparing with other selected compounds.Conclusion: These results are useful for further investigation in the future. 

Authors and Affiliations

Arul K, Sunisha K. S. , Kumaran J

Keywords

Related Articles

SYNTHESIS, ANTIMICROBIAL, ANTITUBERCULAR AND CHEMINFORMATIC STUDIES OF 2-(1-BENZOFURAN-2-YL)-N'-[(3Z)-2-OXO-1, 2-DIHYDRO-3H-INDOL-3-YLIDENE] QUINOLINE-4-CARBOHYDRAZIDE AND ITS DERIVATIVES

Objective: Synthesis of novel 2-(1-benzofuran-2-yl)-N'-[(3Z)-2-oxo-1, 2-dihydro-3H-indol-3-ylidene] quinoline-4-carbohydrazide and its derivatives for antimicrobial and antitubercular activity.Methods: Synthesis was carr...

ACTIVITY ANTI-C. TROPICALIS AND EFFECTS OF THE COMBINATION OF (S)-(-)-CITRONELLAL WITH FOUR ANTIFUNGAL APPLIED IN VULVOVAGINAL CANDIDIASIS

Objective: Assess the antifungal potential of the enantiomer (S)-(-)-citronellal [(S)-(-)-CT] isolated and associated to amphotericin B, fluconazole, itraconazole and miconazole against C. tropicalis from vulvovaginal se...

IN VITRO ANTIOXIDANT ACTIVITY AND GC-MS ANALYSIS OF THE ETHANOLIC EXTRACTS OF TERMINALIA BELLERICA ROXB (BAHEDA)

Objective: To investigate the antioxidant activity of ethanolic extract of Terminalia bellerica fruit pulp (TBFP), seed (TBS) and bark (TBB), and identification of phytochemical constituents of said extracts.Methods: The...

DETERMINATION OF OCTANOL-WATER PARTITION COEFFICIENT OF NOVEL COUMARIN BASED ANTICANCER COMPOUNDS BY REVERSED-PHASE ULTRA-FAST LIQUID CHROMATOGRAPHY

Objective: The present study aims at the development of a reversed phase ultra-fast liquid chromatography (RP-UFLC) method for measurement of the lipophilicity (log P) between n-octanol and water for the newly synthesize...

ACTION RESEARCH AS A TOOL FOR TRANSFORMATION OF THE PHARMACIST’S PRAXIS IN PRIMARY CARE

Objective: Describe and discuss the use of action research in the Pharmaceutical Assistance restructuring of primary care in the city of Lagoa Santa/MG (Brazil), for the implementation of comprehensive medication managem...

Download PDF file
  • EP ID EP579627
  • DOI -
  • Views 82
  • Downloads 0

How To Cite

Arul K, Sunisha K. S. , Kumaran J (2014). IN-SILICO DESIGN, SYNTHESIS AND IN VITRO ANTICANCER AND ANTITUBERCULAR ACTIVITY OF NOVEL AZETIDINONE CONTAINING ISATIN DERIVATIVES. International Journal of Pharmacy and Pharmaceutical Sciences, 6(9), 506-513. https://europub.co.uk/articles/-A-579627